These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 18708261

  • 21. Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.
    Costa RA, Jorge R, Calucci D, Cardillo JA, Melo LA, Scott IU.
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4569-78. PubMed ID: 17003454
    [Abstract] [Full Text] [Related]

  • 22. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [Abstract] [Full Text] [Related]

  • 23. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.
    Algvere PV, Steén B, Seregard S, Kvanta A.
    Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.
    Retina; 2007 Aug; 27(4):439-44. PubMed ID: 17420695
    [Abstract] [Full Text] [Related]

  • 25. Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy.
    Hattori T, Shimada H, Nakashizuka H, Mizutani Y, Mori R, Yuzawa M.
    Retina; 2010 May; 30(5):761-4. PubMed ID: 20453802
    [Abstract] [Full Text] [Related]

  • 26. Predicted biologic activity of intravitreal bevacizumab.
    Stewart MW.
    Retina; 2007 May; 27(9):1196-200. PubMed ID: 18046224
    [Abstract] [Full Text] [Related]

  • 27. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment.
    Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW.
    Retina; 2009 Apr; 29(4):523-9. PubMed ID: 19262441
    [Abstract] [Full Text] [Related]

  • 28. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R, Guthoff T, Meigen T, Goebel W.
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [Abstract] [Full Text] [Related]

  • 29. Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series.
    Donati MC, Virgili G, Bini A, Giansanti F, Rapizzi E, Giacomelli G, Menchini U.
    Ophthalmologica; 2009 Jan; 223(1):24-7. PubMed ID: 18849633
    [Abstract] [Full Text] [Related]

  • 30. Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study.
    Costagliola C, Romano M, Corte MD, Perrotta R, Menzione M, Rinaldi M, Semeraro F, Parmeggiani F.
    Retina; 2009 Oct; 29(9):1227-34. PubMed ID: 19934817
    [Abstract] [Full Text] [Related]

  • 31. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N, Prause JU, Scherfig E, Kiilgaard JF, la Cour M.
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [Abstract] [Full Text] [Related]

  • 32. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A, Moraes N, Farah ME, Bonomo PP.
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract] [Full Text] [Related]

  • 33. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W, Kase S, Ohgami K, Mori S, Ohno S.
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [Abstract] [Full Text] [Related]

  • 34. Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
    Koss MJ, Scholtz S, Haeussler-Sinangin Y, Singh P, Koch FH.
    Ophthalmologica; 2010 May; 224(2):72-8. PubMed ID: 19707030
    [Abstract] [Full Text] [Related]

  • 35. Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration.
    Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, Ohji M.
    Retina; 2010 May; 30(7):1034-8. PubMed ID: 20616682
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C.
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [Abstract] [Full Text] [Related]

  • 37. Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
    Fine HF, Zhitomirsky I, Freund KB, Barile GR, Shirkey BL, Samson CM, Yannuzzi LA.
    Retina; 2009 Jan; 29(1):8-12. PubMed ID: 18784620
    [Abstract] [Full Text] [Related]

  • 38. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study.
    Arevalo JF, Sánchez JG, Wu L, Berrocal MH, Alezzandrini AA, Restrepo N, Maia M, Farah ME, Brito M, Díaz-Llopis M, Rodríguez FJ, Reategui G, Iturralde-Iraola J, Udaondo-Mirete P, Pan-American Collaborative Retina Study Group.
    Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989
    [Abstract] [Full Text] [Related]

  • 39. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK.
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [Abstract] [Full Text] [Related]

  • 40. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.